Management Team
Sudhir Agrawal, D. Phil. ׀ Chief Executive Officer and Chief Scientific Officer
Lou Arcudi ׀ Chief Financial Officer, Treasurer and Secretary
Alice S. Bexon, MBChB. ׀ Vice President, Clinical Development
Timothy M. Sullivan, Ph.D. ׀ Vice President, Development Programs
Ekambar R. Kandimalla, Ph.D. ׀ Vice President, Discovery
Steven J. Ritter, Ph.D., J.D. ׀ Vice President, Intellectual Property and Contracts
David M. Lough, Ph.D. ׀ Director, Business Development and Alliance Management
Frank Whalen, C.P.A. ׀ Controller
Alice S. Bexon, MBChB. ׀ Vice President, Clinical Development
Dr. Bexon joined the Company in 2007. From 2001 to 2006, Dr. Bexon worked for Hoffmann La Roche's Pharma Division, where she served initially as International Medical Leader for the Oncology Business organization and subsequently as Clinical Science Leader for Pharma Development Medical Oncology. Dr. Bexon also served as Medical Director in the oncology business unit of Sanofi-Synthelabo's French affiliate (now Sanofi-Aventis). In addition, Dr. Bexon worked for the European Organization for Research and Treatment of Cancer (subsequently NDDO Oncology) in the Netherlands and Parexel International in France. Dr. Bexon brings a comprehensive knowledge of clinical drug development to the Company, particularly in oncology.
Dr. Bexon received her MB ChB (MD equivalent) from Bristol University Medical School in the UK in 1994 and her full General Medical Council registration to practice medicine the following year. She completed internships in internal medicine and general surgery at Newcastle's Freeman and North Tyneside General Hospitals in the UK and her oncology residency under Professor Jean-Pierre Armand at the Institut Gustave Roussy in Villejuif, France.